| |
Peter Veng-Pedersen, Ph.D.,
Professor,
Division of Pharmaceutics
Contact Information:
Division of Pharmaceutics, S227
College of Pharmacy
The University of Iowa
Iowa City, IA 52242
Phone: (319) 335-8792; Fax: (319) 335-9349
Email: veng@uiowa.edu
Education
1970 B.S. (Pharmacy), University of Copenhagen
1975 M.S. (Pharmacy), University of Sydney
1977 Ph.D. (Pharmacy), University of Sydney
Professional Experience
1991-present, Professor, Division of Pharmaceutics, College of Pharmacy, The University of Iowa
1984-1991, Associate Professor, Division of Pharmaceutics, College of Pharmacy, The University of Iowa
1980-1984, Associate Professor, Department of Pharmaceutics, School of Pharmacy and Pharmacal Sciences, Purdue University
1977-1980, Assistant Professor, Department of Pharmacy and Medicinal Chemistry, School of Pharmacy, University of California San Francisco
Research Interests
Dr. Veng-Pedersen's main research interests include the pharmacokinetics and pharmacodynamics (PK/PD) of erythropoietin in pre-mature, very low birth weight babies, the PK/PD of the insulin-glucose system in diabetic and pre-diabetic subjects, and the kinetic assessment and optimization of drug delivery.
Recent Research Articles (out of more than 146 research article publications)
K. J. Freise, J. A. Widness, R. L. Schmidt, and P. Veng-Pedersen. Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep. Journal of Pharmacokinetics and Pharmacodynamics 35:285-323, (2008).
S. Neelakantan,J. Widness, R. Schmidt, P. Veng-Pedersen. Erythropoietin Pharmacodynamic Analysis Suggests Higher Doses in Treating Neonatal Anemia. Pediatrics International June, 2008.
P. Veng-Pedersen, K.J. Freise, R.L. Schmidt, J.A. Widness, Pharmacokinetic differentiation of drug candidates using system analysis and physiological-based modelling. Comparison of C.E.R.A. and erythropoietin. Journal of Pharmacy and Pharmacology, 60 , 1321-1334, 2008.
K. J. Freise, R. L. Schmidt, J. A. Widness, and P. Veng-Pedersen. Pharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular responsePharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular response. Journal of Pharmacokinetics and Pharmacodynamics. 35:527-552, 2008.
Widness JA, Veng-Pedersen P, Freise KJ, Cress GC, Gingerich EL. Keeping blood in the baby: strategies for reducing blood sampling. Neonatology, 94:228-229, 2008.
Freise KJ, Schmidt RL, Gingerich EL, Veng-Pedersen P and Widness JA. The effect of anticoagulant, storage temperature, and dilution on cord blood hematology indices over time. International Journal of Laboratory Hematology. Int J Lab Hematol. 2008 Apr (2008).
Friese KJ, Widness JA, Schmidt RL, and Veng-Pedersen P. Pharmacokinetic/Pharmacodynamic Analysis of Time-Variant Cellular Disposition: Reticulocyte Disposition Changes in Phlebotomized Sheep. Journal of Pharmacokinetics and Pharmacodynamics. 34, 4, 519-547 (2007).
Friese KJ, Widness JA, Segar JL, Schmidt RL, and Veng-Pedersen P. Increased erythropoietin elimination in fetal sheep following chronic phlebotomy. Pharmaceutical Research. 24, 9 , 1653-1659, (2007).
Gupta N, Al-Huniti NH, Veng-Pedersen P. Individualized Pharmacokinetic Risk Assessment For Development Of Diabetes In High Risk Population. Diabetes Res Clin Pract. 1,93-101(2006).
Widness JA, Schmidt RL, Hohl RJ, Goldman FD, Al-Huniti NH, Freise KJ, Veng-Pedersen P. Change In Erythropoietin Pharmacokinetics Following Hematopoietic Stem Cell Transplantation. Clinical Pharmacology and Therapeutics. 77, 2, 16-26 (2006).
Durairaj L, Neelakantan S, Launspach J, Watt JL, Allaman MM, Kearney WR, Veng-Pedersen P, and Zabner J. Bronchoscopic assessment of airway retention time of aerosolized xylitol. Respir Res. 7(1): 27. (2006).
Warwood TL, Ohls RK, Lambert DK, Jones C, Scoffield SH, Gupta N, Veng-Pedersen P, and Christensen RD. Intravenous administration of darbepoetin to NICU patients. Journal of Perinatology 26, 296–300 (2006).
Warwood TL, Ohls RK, Lambert DK, Leve EA, Veng-Pedersen P, and Christensen RD. Urinary Excretion Of Darbepoetin After Intravenous And Subcutaneous Administration To Preterm Neonates. Journal of Perinatology 26, 636–639 (2006).
Gupta N, Hoffman RP, Veng-Pedersen P. Pharmacokinetic/pharmacodynamic insulin-glucose analysis for differentiation of beta-cell function: an 18 month follow-up study in pre-pubertal lean and obese children. Biopharmaceutics & Drug Disposition27, 6 , 257 – 265 (2006).
Neelakantan S, Widness JA, Schmidt RL, and Veng-Pedersen P. A “Bottom-Up” Approach For Endo-Pk/Pd Analysis. Biopharmaceutics and Drug Disposition. 27,313-327 (2006).
|
|
